Keywords: Novo Nordisk, R&D collaboration, JDRF, Types 1 and 2 diabetes, Basal insulin

Novo Nordisk links with JDRF on type 1 diabetes R&D; type 2 study results

Article | 14 June 2012

Print This

Danish insulin giant Novo Nordisk (NOV: N) is partnering with the US charitable organization JDRF to discover and develop novel ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in